Edward Brian Garon MD
Assistant Professor, Medicine, UCLA School of Medicine
Join to View Full Profile
2020 Santa Monica Blvd., 6th FloorSanta Monica, CA 90404
Phone+1 310-829-5471
Fax+1 310-829-5471
Dr. Garon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
University of ChicagoResidency, Internal Medicine, 1999 - 2002
Washington University in St. Louis School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2003 - 2026
IL State Medical License 1999 - 2005
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 28
- Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2009 Jan 01
- Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 01
- Join now to see all
Publications & Presentations
PubMed
- Immune Checkpoint Inhibitor Myocarditis Masquerading as Brugada Syndrome.Aleksandr Talishinsky, Kinan Bachour, Charlie Lin, Patrick Zakka, Khalil Bassam
JACC. Case Reports. 2025-10-15 - Corrigendum to "Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy Fo...Marina C Garassino, Shirish Gadgeel, Silvia Novello, Balazs Halmos, Enriqueta Felip
JTO Clinical and Research Reports. 2025-10-01 - Characteristics of clinical trials associated with appeal and return on investment to participants, A Review and Framework.Maria J Fernandez Turizo, Maria A Velez, Beth Glenn, Amy L Cummings, Barbara Segarra-Vazquez
The Oncologist. 2025-09-27
Journal Articles
- Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung CancerEdward B Garon, Maeve Waldron-Lynch, The New England Journal of Medicine
Lectures
- Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001.2019 ASCO Annual Meeting - 6/1/2019
- Safety and activity of durvalumab + tremelimumab in immunotherapy (IMT)-pretreated advanced NSCLC patients.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- Responses and durability in NSCLC treated with pegilodecakin and anti-PD-1.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Authored Content
- Controversies, Difficult Questions Arise in NSCLC Amid New DataFebruary 2024
Press Mentions
ESMO: 10-Year Survival Data for Lung Cancer Immunotherapy, New PSMA-Targeted Therapy for Recurrent Prostate Cancer, Promising Results in Metastatic Colorectal and Urothelial CancersOctober 20th, 2025- Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS CongressApril 26th, 2025
- Dr. Garon on Considerations Regarding the Use of Perioperative Immunotherapy in Lung CancerJuly 4th, 2024
- Join now to see all
Grant Support
- HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapyUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028
- HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapyUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028
- Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
